At a Glance
| Methcathinone | MDA | |
|---|---|---|
| Class | Entactogen, Stimulants | Psychedelic, Entactogen, Stimulants |
| Common Dose (oral) | 100–200 mg | 60–100 mg |
| Total Duration | — | 3.3–6.3 hrs |
| Routes | oral | oral |
| Effects | 32 documented | 81 documented |
Methcathinone, a Entactogen, Stimulants, and MDA, a Psychedelic, Entactogen, Stimulants, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Methcathinone is classified as a Entactogen, Stimulants while MDA is a Psychedelic, Entactogen, Stimulants, meaning they approach altered states through different pharmacological mechanisms. They share 26 documented effects in common, with 6 effects unique to Methcathinone and 55 unique to MDA. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Methcathinone | MDA | |
|---|---|---|
| Class | Entactogen, Stimulants | Psychedelic, Entactogen, Stimulants |
| Common Dose (oral) | 100–200 mg | 60–100 mg |
| Total Duration | — | 3.3–6.3 hrs |
| Routes | oral | oral |
| Effects | 32 documented | 81 documented |
| Interaction |
| Caution |
| Level | Methcathinone | MDA |
|---|---|---|
| Threshold | 25 mg | 20 mg |
| Light | 50–100 mg | 40–60 mg |
| Common | 100–200 mg | 60–100 mg |
| Strong | 200–300 mg | 100–145 mg |
| Heavy | 300 mg | 145 mg |
Methcathinone
MDA
Increased cardiovascular strain and neurotoxicity risk